US Broker Ratings

Alcon Inc. (ALC) Stock Analysis: Evaluating Growth Potential with a 15.91% Upside

Alcon Inc. (NYSE: ALC), a leading global player in the healthcare sector, particularly in Medical Instruments & Supplies, presents an intriguing prospect for investors looking to..

Edwards Lifesciences (EW) Stock Analysis: 27% Potential Upside Captures Investor Attention

Edwards Lifesciences Corporation (EW), a stalwart in the healthcare sector, operates within the medical devices industry. With a market capitalization of $44.54 billion, this California-based company..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a Challenging Landscape with Strategic Collaborations

As a prominent player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has captured significant investor attention, particularly due to its groundbreaking mRNA technology and its..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 60% Upside Potential in the Healthcare Information Sector

Doximity, Inc. (NYSE: DOCS), a prominent player in the healthcare information services industry, offers a digital platform tailored for medical professionals in the United States. With..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and 21.66% Potential Upside Attract Investors

Globus Medical, Inc. (NYSE: GMED) stands as a formidable player in the medical device sector, particularly noted for its innovative solutions in musculoskeletal healthcare. As a..

BioNTech SE (BNTX) Stock Analysis: Navigating Potential Upside of 32.74% Amidst Biotech Innovations

BioNTech SE (NASDAQ: BNTX) stands as a prominent player in the healthcare sector, specifically within the biotechnology industry. Based in Germany, the company has carved a..

Repligen Corporation (RGEN) Stock Analysis: A Potential 39.91% Upside with Strong Buy Ratings

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specializes in developing cutting-edge bioprocessing technologies and systems. With a market capitalization of $7.68 billion,..

Cencora, Inc. (COR) Stock Analysis: Exploring a 11.74% Upside Potential

Cencora, Inc. (NYSE: COR), formerly known as AmerisourceBergen Corporation, has recently undergone a significant rebranding, yet it continues to command attention in the healthcare sector as..

Exelixis, Inc. (EXEL) Investor Outlook: Navigating Potential Upside in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, stands at an intriguing juncture for investors. With a market capitalization of $11.78 billion, Exelixis..

The Cooper Companies, Inc. (COO) Stock Analysis: Discovering a 9.65% Upside Potential Amidst Robust Healthcare Innovations

The Cooper Companies, Inc. (NYSE: COO) has carved a niche in the healthcare industry, specifically within the medical instruments and supplies sector. With a solid market..

Eli Lilly (LLY) Stock Analysis: A Healthcare Giant with a 15.54% Upside Potential

Eli Lilly and Company (NYSE: LLY) has established itself as a formidable player in the healthcare sector, particularly in the pharmaceutical industry. With a staggering market..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with a 9.31% Potential Upside

Baxter International Inc. (NYSE: BAX) stands as a stalwart in the healthcare sector, offering a diverse portfolio of medical instruments and supplies. Headquartered in Deerfield, Illinois,..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Summit Therapeutics Inc. (SMMT) Stock Analysis: A Biotech Gem with a 119.78% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT) stands out in the competitive healthcare sector as a biotech company with a compelling growth narrative. Headquartered in Miami, Florida, Summit..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Growth with a 6.62% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, with a robust market capitalization of $14.94 billion. Headquartered in King..

Royalty Pharma (RPRX): Unveiling a 12.86% Upside Potential with Strong Buy Ratings

Royalty Pharma plc (NASDAQ: RPRX) is a unique player in the biotechnology sector, offering investors exposure to a diversified portfolio of biopharmaceutical royalties. With a market..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating Growth with 6.32% Potential Upside

Align Technology, Inc. (NASDAQ: ALGN), a leader in the healthcare sector specializing in medical instruments and supplies, has been on the radar of savvy investors, particularly..

Stryker Corporation (SYK) Stock Analysis: Navigating a 15.94% Potential Upside in the Healthcare Sector

Stryker Corporation (NYSE: SYK) stands out in the healthcare sector, particularly in the medical devices industry, with a market capitalization of approximately $140.08 billion. Headquartered in..

ICON plc (ICLR) Stock Analysis: Unveiling an 87.74% Potential Upside in Healthcare Diagnostics

ICON plc (ICLR), a prominent player in the global healthcare diagnostics and research industry, stands as a compelling opportunity for investors seeking growth in the healthcare..

Hologic, Inc. (HOLX) Stock Report: Unpacking the 2.08% Upside Potential for Investors

Hologic, Inc. (HOLX), a healthcare giant in the medical instruments and supplies industry, is capturing investor attention with its promising outlook and recent performance metrics. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds